Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease would benefit from validated small animal models. Here, we show that transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) by the human cytokeratin 18 promoter (K18 hACE2) represent a susceptible rodent model. K18 hACE2 transgenic mice succumbed to SARS-CoV-2 infection by day 6, with virus detected in lung airway epithelium and brain. K18 ACE2 transgenic mice produced a modest TH1/2/17 cytokine storm in the lung and spleen that peaked by day 2, and an extended chemokine storm that was detected in both lungs and brain. This chemokine storm was also detected in the brain at day 6. K18 hACE2 transgenic mice are, therefore, highly susceptible to SARS-CoV-2 infection and represent a suitable animal model for the study of viral pathogenesis, and for identification and characterization of vaccines (prophylactic) and antivirals (therapeutics) for SARS-CoV-2 infection and associated severe COVID-19 disease.
Article activity feed
-
-
SciScore for 10.1101/2020.07.18.210179: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: Ethics statement: All experimental procedures with animals were approved by the Texas Biomedical Research Institute (Texas Biomed) Institutional Biosafety Committee (IBC, #20-004 and #20-010) and Institutional Animal Care and Use Committee (IACUC, #1708 MU) and under Biosafety Level 3 (BSL3) and animal BSL3 (ABSL3) facilities at Texas Biomed. Randomization not detected. Blinding Sections were stained with Haemotoxylin and Eosin (H&E) and evaluated using light microscopy in a blinded manner by a board certified veterinary pathologist. Power Analysis not detected. Sex as a biological variable Mice: Specific-pathogen-free, 4-5-weeks-old, female and male … SciScore for 10.1101/2020.07.18.210179: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: Ethics statement: All experimental procedures with animals were approved by the Texas Biomedical Research Institute (Texas Biomed) Institutional Biosafety Committee (IBC, #20-004 and #20-010) and Institutional Animal Care and Use Committee (IACUC, #1708 MU) and under Biosafety Level 3 (BSL3) and animal BSL3 (ABSL3) facilities at Texas Biomed. Randomization not detected. Blinding Sections were stained with Haemotoxylin and Eosin (H&E) and evaluated using light microscopy in a blinded manner by a board certified veterinary pathologist. Power Analysis not detected. Sex as a biological variable Mice: Specific-pathogen-free, 4-5-weeks-old, female and male B6.Cg-Tg(K18-ACE2)2Prlmn/J (Stock No: 034860, K18 hACE2) hemi-zygotes, or wild-type (WT) C57BL/6 control mice, were purchased from The Jackson Laboratory (Bar Harbor, ME). Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources The primary antibodies were detected with goat anti-rabbit-AP developed with Permanent Red warp (mach3 Biocare Medical). anti-rabbit-APsuggested: NoneExperimental Models: Cell Lines Sentences Resources Measurement of viral loads: Confluent monolayers of Vero E6 cells (96-well plate format, 4 x 104 cells/well, duplicates) were infected with 10-fold serial dilutions of supernatants obtained from the organ homogenates. Vero E6suggested: NoneExperimental Models: Organisms/Strains Sentences Resources Mice: Specific-pathogen-free, 4-5-weeks-old, female and male B6.Cg-Tg(K18-ACE2)2Prlmn/J (Stock No: 034860, K18 hACE2) hemi-zygotes, or wild-type (WT) C57BL/6 control mice, were purchased from The Jackson Laboratory (Bar Harbor, ME). B6.Cg-Tg(K18-ACE2)2Prlmn/Jsuggested: RRID:IMSR_JAX:034860)C57BL/6suggested: NoneSoftware and Algorithms Sentences Resources After incubation with the primary NP MAb, cells were washed three times with PBS, and developed with the Vectastain ABC kit and DAB Peroxidase Substrate kit (Vector Laboratory, Inc., CA, USA) according to the manufacturers’ instructions. Vector Laboratorysuggested: NoneStatistical analysis: Statistical significance was determined using Prism 8 software (GraphPad Software, San Diego, CA). Prismsuggested: (PRISM, RRID:SCR_005375)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:While our findings clearly identify the K18 hACE2 transgenic mouse as a model for SARS-CoV-2 infection and COVID-19 disease, our studies have some limitations. The primary limitation was the number of mice that were available for study, due to limited supply from the vendor. We maximized our studies by performing two independent experiments that cross-validated each other in survival and pathogenesis results. Both studies showed considerable sensitivity of K18 hACE2 transgenic mice to SARS-CoV-2 infection. We chose a relatively high viral dose (MOI 1x105 PFU/mouse) that was capable of causing extensive disease, but we were unable to include additional time points to further understand the time course of immune responses (e.g. 1-DPI) or whether the chemokine and cytokine storm increased again at study endpoints (e.g. 5/6-DPI). Likewise, the limited number of K18 hACE2 transgenic mice did not allow us to use different viral doses to calculate the mouse lethal dose 50 (MLD50) of SARS-CoV-2. Inclusion of WT C57BL/6 control mice in our studies confirmed that mice are not naturally susceptible to infection with SARS-CoV-2 without experimental manipulation to express hACE2, further confirming that hACE2 is the receptor for SARS-CoV-2.56–59 Several groups are developing large animal models of SARS-CoV-2 infection and COVID-19, with a primary focus on nonhuman primates (NHP) models. Reports indicate that macaques develop self-limiting disease with a strong anamnestic responses (innate...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
-